Danijela Jelovac

Assistant Professor

20012017
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
letrozole Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Estrogen Receptor Modulators Medicine & Life Sciences
Aromatase Medicine & Life Sciences
Heterografts Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2017

A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology Study (NCT#01281852)

Thaker, P. H., Salani, R., Brady, W. E., Lankes, H. A., Cohn, D. E., Mutch, D. G., Mannel, R. S., Bell-McGuinn, K. M., Di Silvestro, P. A., Jelovac, D., Carter, J. S., Duan, W., Resnick, K. E., Dizon, D. S., Aghajanian, C. & Fracasso, P. M., 2017, In : Annals of Oncology. 28, 3, p. 505-511 7 p.

Research output: Contribution to journalArticle

Cervix Uteri
Carcinoma
Fanconi Anemia
Focus Groups
Uterine Cervical Neoplasms

Whole-cell vaccines

Jelovac, D. & Emens, L. A., Jan 1 2017, Cancer Therapeutic Targets. Springer New York, Vol. 1-2, p. 561-574 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cancer Vaccines
Tumors
Vaccines
T-cells
Neoplasms
Cross-Sectional Studies
Breast Neoplasms
Chemoprevention
Risk Reduction Behavior
Reproductive History

Emerging immunotherapies in ovarian cancer

Ojalvo, L. S., Nichols, P. E., Jelovac, D. & Emens, L. A., 2015, In : Discovery medicine. 20, 109, p. 97-109 13 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Immunotherapy
Neoplasms
Cancer Vaccines
Tumor Microenvironment

Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer

Kim, K. H., Jelovac, D., Armstrong, D. K., Schwartz, B., Weil, S. C., Schweizer, C. & Alvarez, R. D., Sep 8 2015, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Carboplatin
Platinum
Safety
Neutropenia
Fatigue